Skip to main content

A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus

Completed

Despite the worldwide effort to develop safe and effective vaccines against COVID-19 and ramp up production capacity, it is inevitable that initial vaccine supply will be limited. Therefore, policymakers must develop plans to ensure the equitable allocation of limited doses until there is sufficient global supply.

In response to a request from the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC), the National Academies have formed a committee that will produce a consensus study to assist policymakers in the U.S. and global health communities in planning for equitable allocation of vaccines against COVID-19.

Meetings
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.